BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 3459577)

  • 1. Treatment of refractory acute lymphoblastic leukemia with teniposide and cytarabine.
    Kamen BA; Casper J; Lauer S; Camitta BM; Holcenberg JS
    Cancer Treat Rep; 1986 Jul; 70(7):935-6. PubMed ID: 3459577
    [No Abstract]   [Full Text] [Related]  

  • 2. Teniposide and cytarabine combination chemotherapy in the treatment of relapsed adolescent and adult acute lymphoblastic leukemia.
    Sanz GF; Sanz MA; Rafecas FJ; Martínez JA; Martín-Aragonés G; Marty ML
    Cancer Treat Rep; 1986 Nov; 70(11):1321-3. PubMed ID: 3464352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acute lymphoblastic leukemia of high risk: results of a therapeutic protocol].
    Castel V; Verdeguer A; Ferris J; Esquembre C
    An Esp Pediatr; 1987 Nov; 27(5):331-4. PubMed ID: 3481522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [VM-26 and cytosine arabinoside in the treatment of acute refractory lymphoblastic leukemia in adults].
    Marín P; Grañena A; Carreras E; Sierra J; Olivé MT; Rozman C
    Sangre (Barc); 1984; 29(4-A):399-404. PubMed ID: 6594782
    [No Abstract]   [Full Text] [Related]  

  • 5. [Large doses of cytarabine, etoposide and methotrexate (CEM protocol) in the treatment of lymphoblastic leukemia in adults, resistant to conventional treatment, and of recurrences].
    Robak T; Krykowski E; Matusewicz W; Olszańska-Skorek T; Urbańska-Ryś H
    Pol Tyg Lek; 1988 Mar; 43(11):351-4. PubMed ID: 3166135
    [No Abstract]   [Full Text] [Related]  

  • 6. [Results of the treatment of lymphoblastic leukemia by the BFM program in children--a 5-year observation].
    Rokicka-Milewska R; Derulska D; Makowska K; Skwarska E; Lewicki Z
    Acta Haematol Pol; 1987; 18(1-2):1-8. PubMed ID: 3481150
    [No Abstract]   [Full Text] [Related]  

  • 7. [Consolidating chemotherapy in the treatment program of acute lymphoblastic leukemia in children].
    Maiakova SA; Makhonova LA
    Vestn Akad Med Nauk SSSR; 1986; (5):15-7. PubMed ID: 3487897
    [No Abstract]   [Full Text] [Related]  

  • 8. Teniposide (VM-26) and cytosine arabinoside as consolidation therapy in adult high-risk patients with acute lymphoblastic leukemia.
    Hoelzer D; Thiel E; Löffler H; Büchner T; Ganser A; Heil G; Kurrle E; Heimpel H; Koch P; Lipp T
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):92-7. PubMed ID: 3473688
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of ocular leukemia with local chemotherapy.
    Rootman J; Gudauskas G
    Cancer Treat Rep; 1985 Jan; 69(1):119-22. PubMed ID: 3855383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acute refractory lymphoblastic leukemia in the adult. Treatment with daunorubicin, cytosine arabinoside, 6-thioguanine, vincristine and prednisone].
    Marín P; Grañena A; Carreras E; Ribera JM; Rozman C
    Sangre (Barc); 1984; 29(6):987-92. PubMed ID: 6598237
    [No Abstract]   [Full Text] [Related]  

  • 11. Teniposide (VM-26) and ara-C in the treatment of adult acute lymphoblastic leukemia.
    Linker CA; Levitt LJ; O'Donnell M; Ries CA; Forman SJ
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):78-85. PubMed ID: 3473686
    [No Abstract]   [Full Text] [Related]  

  • 12. The epipodophyllotoxin teniposide in therapy for childhood acute lymphocytic leukemia.
    Rivera GK
    J Clin Oncol; 1988 Feb; 6(2):191-3. PubMed ID: 3276820
    [No Abstract]   [Full Text] [Related]  

  • 13. VM-26 and cytarabine combination chemotherapy in refractory or relapsed adult acute lymphoblastic leukemia.
    Carella AM; Santini G; Martinengo M; Giordano D; Nati S; Congiu A; Risso M; Vimercati R; Cerri R; Rossi E
    Haematologica; 1984; 69(6):747-51. PubMed ID: 6441752
    [No Abstract]   [Full Text] [Related]  

  • 14. [Intensification of treatment of lymphoblastic leukemia in children].
    Michalewska D; Radwańska U
    Pediatr Pol; 1985 Jan; 60(1):5-13. PubMed ID: 3862059
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of acute lymphoblastic leukemia in children: modified LSA2-L2 therapy].
    Ishii E; Hara T; Ueda K; Kishida K; Nakamura E; Miyazaki S; Yoshida N
    Rinsho Ketsueki; 1985 Apr; 26(4):487-93. PubMed ID: 3862888
    [No Abstract]   [Full Text] [Related]  

  • 16. Intermediate dose methotrexate and sequential L-asparaginase for treatment of refractory acute lymphocytic leukaemia.
    Shetty PA; Kurkure PA; Dasgupta A
    Indian J Cancer; 1984; 21(1):45-9. PubMed ID: 6595214
    [No Abstract]   [Full Text] [Related]  

  • 17. Alternating pulses of vincristine-prednisone with cytarabine-cyclophosphamide versus vincristine-prednisone in the maintenance therapy of acute lymphoblastic leukemia.
    Sackmann Muriel F; Svarch E; Pavlovsky S; Bustelo P; Giuntoli J; Vergara B; Garay G; Eppinger-Helft M; Kvicala R; Dibar E
    Cancer Treat Rep; 1984 Apr; 68(4):581-6. PubMed ID: 6370428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose Ara-C plus VM-26 in adult acute lymphoblastic leukemia.
    Larson RA; Gaynor ER; Shepard KV; Daly KM
    Eur J Cancer Clin Oncol; 1985 Oct; 21(10):1261-3. PubMed ID: 3865776
    [No Abstract]   [Full Text] [Related]  

  • 19. Intermediate dose methotrexate (IDM) in children with acute lymphocytic leukemia (ALL). An update.
    Freeman AI
    Sangre (Barc); 1985; 30(6):1007-33. PubMed ID: 3913034
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of refractory non-Hodgkin's lymphomas of unfavorable histology with teniposide, cytarabine, and cisplatin.
    Tseng A; Jacobs C; Coleman CN; Horning SJ; Lewis BJ; Rosenberg SA
    Cancer Treat Rep; 1987 Jun; 71(6):659-60. PubMed ID: 3581106
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.